Conflict of interest statement: There are no conflicts of interest.189. South Asian J Cancer. 2018 Apr-Jun;7(2):87-90. doi: 10.4103/sajc.sajc_108_18.Practical consensus recommendations regarding role of postmastectomy radiationtherapy.Singh D(1), Saini G(1), Koul R(2), Gupta V(3), Abrol D(4), De S(5), KulshresthaP(6), Hukku SN(7), Lakshmi SJ(8), Parikh PM(9), Aggarwal S(10).Author information: (1)Department of Radiation Oncology, Max Hospital, Noida, Uttar Pradesh, India.(2)Department of Surgical Oncology, Sir Ganga Ram Hospital, New Delhi, India.(3)Department of Surgical Oncology, BLK Super Specialty Hospital, New Delhi,India.(4)Department or Radiation Oncology, Jammu Medical College, Jammu, Jammu andKashmir, India.(5)Department of Radiation Oncology, Jaypee Hospital, Noida, Uttar Pradesh,India.(6)Department of Radiation Oncology, Metro Hospital and Cancer Institute, NewDelhi, India.(7)Department of Radiation Oncology, BLK Super Specialty Hospital, New Delhi,India.(8)Department of Radiation Oncology, Artemis Hospital, Gurugram, Haryana, India.(9)Department of Oncology, Shalby Cancer and Research Institute, Mumbai,Maharashtra, India.(10)Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.The use of radiation therapy after mastectomy (PMRT) has been limited to thosepatients who are at significant risk of cancer recurring in the chest wall or in the nodal basins. The use of PMRT has been widely accepted for patients with fouror more positive lymph nodes,[1],[2] but there is still controversy regarding thevalue of PMRT for those with one to three positive nodes. This expert group used data from published literature, practical experience and opinion of a large groupof academic oncologists to arrive at these practical consensus recommendationsfor the benefit of community oncologists.DOI: 10.4103/sajc.sajc_108_18 PMCID: PMC5909302PMID: 29721470 